RYTM
Rhythm Pharmaceuticals Inc
99.30$
+0.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 1,971.4% | 19.0% | 9.0% | 12.0% | 10.3% | 10.3% | |
| – | – | – | – | – | – | -1,971.4% | 81.0% | 91.0% | 88.0% | 89.7% | 89.7% | |
| – | – | – | – | – | – | 258,428.6% | 3,301.5% | 459.6% | 174.3% | 182.9% | 88.2% | |
| – | – | – | – | – | – | 131,785.7% | 2,171.4% | 389.3% | 144.0% | 110.9% | 102.7% | |
| – | – | – | – | – | – | 390,214.3% | 5,472.9% | 848.9% | 326.1% | 293.8% | 190.9% | |
| – | – | – | – | – | – | -390,214.3% | -5,391.9% | -757.9% | -238.1% | -204.0% | -101.2% | |
| – | – | – | – | – | – | 0.0% | 3,184.7% | 22.0% | 17.9% | 15.8% | 10.8% | |
| – | – | – | – | – | – | -382,845.7% | -2,207.1% | -766.2% | -237.8% | -200.0% | -103.3% | |
| – | – | – | – | – | – | -9,340.0% | -50.9% | 8.3% | 0.7% | 0.3% | 0.3% | |
| – | – | – | – | – | – | -373,505.7% | -2,156.2% | -766.2% | -238.5% | -200.3% | -103.6% | |
| – | – | – | – | – | – | -388,242.9% | -5,355.1% | -737.1% | -217.6% | -183.0% | -91.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.